Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer
Prostate cancer (PC) is one of the most common cancers and is a leading cause of death. Its initial growth is dependent on androgens; most patients show an initial response to hormonal therapy but will experience disease progression when PC becomes resistant to castration. In 2004, two key randomize...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2013-01-01
|
| Serie: | Clinical Medicine Insights: Oncology |
| Accesso online: | https://doi.org/10.4137/CMO.S7256 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|